Peer-reviewedCC BY-NC-ND 4.0Journal of Infection
A Rapid and simple method for quantifying rezafungin in human plasma
Abstract
There is no fully described method in the literature for quantifying rezafungin in human plasma or other biological matrices. Most in vivo or clinical studies investigating rezafungin specify only brief analytical methodological details. In our university hospital, we have adapted the ready-to-use commercial kit developed by ChromSystems for therapeutic monitoring of several antifungal agents in plasma for use with rezafungin. This industrial-grade analytical method can be implemented quickly and easily in medical laboratories equipped with a chromatographic system coupled with a tandem mass spectrometer.
Related
- A rapid and simple method for inactivating chromosomal genes in Yersinia
- scRIPT: a rapid, high-coverage single-cell lineage-tracing method applied to the hematoendothelial differentiation of embryonic stem cells
- Quantifying the Effect of Encapsulation on Microbial Mineralization Processes Using a Modified DNA Extraction Method
- A simple and cost-effective denaturation-reannealing multiplex PCR (drmPCR) method for discriminating late-feathering genotypes in male Korean indigenous breed chickens.
- A simple and accurate method for inferring missing ploidy information from sequence data
BibTeX
@article{aubinbeale2026rapid,
title = {{A Rapid and simple method for quantifying rezafungin in human plasma}},
author = {Eyrian Aubin-Beale and Maxime Kolmayer and Alan Kolodziej and Heiko Palma and Emmanuel Novy and Pierre Gillet and Elise Pape and Julien Scala-Bertola},
journal = {Journal of Infection},
year = {2026},
month = sep,
doi = {10.1016/j.jinf.2026.106867},
url = {https://hal.science/hal-05773192v1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - A Rapid and simple method for quantifying rezafungin in human plasma
AU - Eyrian Aubin-Beale
AU - Maxime Kolmayer
AU - Alan Kolodziej
AU - Heiko Palma
AU - Emmanuel Novy
AU - Pierre Gillet
AU - Elise Pape
AU - Julien Scala-Bertola
PY - 2026
DA - 2026/09/26
JO - Journal of Infection
DO - 10.1016/j.jinf.2026.106867
UR - https://hal.science/hal-05773192v1
AB - There is no fully described method in the literature for quantifying rezafungin in human plasma or other biological matrices. Most in vivo or clinical studies investigating rezafungin specify only brief analytical methodological details. In our university hospital, we have adapted the ready-to-use commercial kit developed by ChromSystems for therapeutic monitoring of several antifungal agents in plasma for use with rezafungin. This industrial-grade analytical method can be implemented quickly and easily in medical laboratories equipped with a chromatographic system coupled with a tandem mass spectrometer.
SN - 0163-4453
SN - 1532-2742
ER -